7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

NeuroBo Pharmaceuticals, Inc.
(NASDAQ:NRBO) 

NRBO stock logo

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with mode...

Founded: 2017
CEO: Richard Kang  
Sector: Healthcare
Industry: Biotechnology
Healthcare
Share this website to your friends
NeuroBo Pharmaceuticals . Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 034.4368.86103.3137.73172.16206.59241.02Thousand
NeuroBo Pharmaceuticals . Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -11.31-9.7-8.08-6.46-4.85-3.23-1.620
NeuroBo Pharmaceuticals . Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -11.31-9.7-8.08-6.46-4.85-3.23-1.620
NeuroBo Pharmaceuticals . Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 04.899.7914.6819.5824.4729.3734.26
NeuroBo Pharmaceuticals . P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0679.841,359.672,039.512,719.343,399.184,079.014,758.85
NeuroBo Pharmaceuticals . (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -40.57-34.77-28.98-23.18-17.39-11.59-5.80
NeuroBo Pharmaceuticals . P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.683.365.046.728.410.0811.76
No extra charts and metrics for this ticker.